Researchers identify a key pathway leading to neurodegeneration in early stages of ALS, hinting at the potential for short-circuiting the progression of the fatal disease if diagnosed early.

Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing ...

Medical professionals believe the treatment, which genetically alters the immune system to identify and target problematic ..

Lupus is typically treated with anti-inflammatory medicines like ibuprofen, hydroxychloroquine for fatigue and skin and joint ...

Arthritis is a common acute or chronic condition affecting the joints and surrounding tissues. It’s estimated that roughly 18 ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial ...

Sitting in A&E aged just 19 and in her second year of university with agonising, swollen ankles, it dawned on Rachel Hall how ...

Lupus is a chronic autoimmune disorder that triggers inflammation in organs and joints, affects mobility, impacts skin health ...

Objective Lupus nephritis (LN) is a major cause of morbidity and mortality, affecting up to 60% of patients with systemic lupus erythematosus (SLE). The perspectives of patients with SLE have been ...

An awareness-raising campaign from the nation’s leading kidney patient support charity has received the backing of people ...

There is a clinical study underway that is testing whether an investigational medicine is safe and whether it may work for ...

In a new study, researchers identify biomarkers that may predict the efficacy of low-dose IL-2 (Ld-IL2) treatment in people with systemic lupus erythematosus (SLE). IL-2 stands for interleukin-2 – a ...